Events

Marie Skłodowska-Curie Actions Staff Exchanges 2022 call Info Session
DEC
Wed
07
10:30 - 12:30

This was 2 years ago

Location

virtual

Programmes
MSCA

The Directorate General for Education, Youth, Sport & Culture (EAC) of the European Commission and the European Research Executive Agency (EREA) organise a web-streamed info session, dedicated to the 2022 MSCA Staff Exchanges call for proposals. Participants will receive key information on the main features and impact of the Staff Exchanges Action and the application process.

Programme

10:30 - 10:45 Welcome and opening remarks

10:45 - 11:00 MSCA Policy context

11:00 - 11:30 Cooperation between business and academia: Live discussion

11:30 - 12:10 All you need to know about Staff Exchanges

12:10 - 12:25 Q&A (Slido)

12:25 - 12:30 Closing of event

Recording

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.